Peggy N Atmodimedjo Selected Research

Peggy N Atmodimedjo Research Topics

13	Neoplasms (Cancer) 01/2023 - 11/2015
4	Glioma (Gliomas) 01/2020 - 01/2016
3	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 10/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2020
2	Carcinogenesis 07/2021 - 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Disease Progression 04/2024
1	Central Nervous System Neoplasms 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 08/2021
1	Carcinoma (Carcinomatosis) 08/2021
1	Adenocarcinoma 08/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Microsatellite Instability 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Adrenocortical Carcinoma 10/2017
1	Melanoma (Melanoma, Malignant) 10/2016
1	Oligodendroglioma 01/2016

4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2015
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 10/2018
3	Circulating Tumor DNAIBA 04/2024 - 10/2017
3	Cell-Free Nucleic AcidsIBA 08/2021 - 10/2017
2	ParaffinIBA 01/2020 - 01/2016
2	Formaldehyde (Formol)FDA Link 01/2020 - 01/2016
2	Procarbazine (Matulane)FDA Link 01/2018 - 03/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
1	sotorasibIBA 04/2024
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	MethyltransferasesIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-3IBA 10/2016
1	Vincristine (Oncovin)FDA LinkGeneric 03/2016
1	Lomustine (CCNU)FDA Link 03/2016